← European Medicine Shortage Tracker · all medicines
Pancrelipasi currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: PANCRELIPASI · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Pancrelipasi, covering 3 affected product presentations. The longest-running open report was filed in Italy on 2022-01-01 and has now been open for about 55 months. Where agencies state a cause, manufacturing problems lead with 2 of the 3 stated-cause reports, followed by unexpectedly high demand with 1. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-31. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage CREON + 2 more productsCREON CREONIPE | 2022-01-01 | 2026-12-31 | Elevata richiesta/problemi produttivi: distribuzione contingentata Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Pancrelipasi in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | CREON | Shortage | 2026-09-20 | — | Elevata richiesta: distribuzione contingentata |
| 🇮🇹 IT | CREONIPE | Shortage | 2023-09-15 | 2026-12-31 | Problemi produttivi: distribuzione contingentata |
| 🇮🇹 IT | CREON | Shortage | 2022-01-01 | 2026-12-31 | Elevata richiesta/problemi produttivi: distribuzione conting |
Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Pancrelipasi: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Pancrelipasi — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pancrelipasi/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Pancrelipasi availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pancrelipasi/">Pancrelipasi shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>